drugset / Trial / NCT00003815

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00003815 ↗

RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy and radiation therapy plus bone marrow transplantation in treating patients who have aggressive non-Hodgkin's lymphoma.

Timeline

Start
1994-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown — Intravenous
Subject Cyclophosphamide Other / unclassified — —
Subject Cytarabine Small molecule — Intravenous
Subject Doxorubicin Other / unclassified — Intravenous
Subject Etoposide Small molecule — Oral
Subject Melphalan Small molecule — Intravenous
Subject Prednisolone Other / unclassified — Oral
Subject Vincristine Small molecule — —
Subject carmustine Small molecule — Intravenous

Indications